LLASHNEWSMedical aesthetics media & sourcingRequest Quote
Company NewsAesthetic Devices

【United State】Estée Lauder Remains Open to M&A After Failed Puig Merger

Source image preserved for article context.
Editor's note

This report relies on five sources with direct knowledge and CEO Stéphane de La Faverie's public remarks. For buyers, the failed merger signals ongoing consolidation risk in premium beauty supply chains, while the CEO's pricing stance raises regulatory questions about future deal structures and potential shifts in brand ownership.

Estée Lauder remains open to acquisitions that make financial sense, CEO Stéphane de La Faverie said Tuesday, after the collapse of merger talks with Spanish beauty group Puig. The failed deal, which would have created a luxury beauty giant better positioned to compete with L'Oréal, fell apart over pricing disagreements. For overseas aesthetic buyers and distributors, the news signals continued consolidation pressure in the premium beauty supply chain, with potential shifts in brand ownership and distribution strategies.

Failed merger details

Estée Lauder and Puig ended negotiations late last month that would have formed a high-end beauty powerhouse. Five sources with direct knowledge told Reuters that leaks, disagreements among powerful controlling families, and demands from figures including makeup mogul Charlotte Tilbury contributed to the collapse. De La Faverie confirmed at a Deutsche Bank consumer goods conference in Paris that price was the decisive factor.

CEO's pricing stance

"If we cannot get growth and profitability at the right price, then it's not an option. And that's why, of course, the deal did not proceed — it was not at the right price," De La Faverie said. He added that the company will continue to seek opportunities. The statement underscores Estée Lauder's disciplined approach to M&A amid a challenging market environment.

Cost-cutting and restructuring

In May, the owner of Clinique and M.A.C. announced plans to cut 9,000 to 10,000 jobs globally as part of its accelerated "Beauty Reimagined" strategy. The restructuring aims to generate up to $1.2 billion in annual savings. These moves reflect broader industry trends where major players are streamlining operations to maintain margins while investing in growth categories.

What buyers should watch

For medical aesthetics and beauty supply-chain buyers, the failed merger and ongoing restructuring suggest Estée Lauder may pursue targeted acquisitions in high-growth segments such as clinical skincare or injectable-adjacent brands. Distributors should monitor potential portfolio adjustments that could create new sourcing opportunities or shift brand distribution rights. The company's focus on financial discipline may also lead to more selective partnerships and tighter inventory management across its supply chain.

Source: Read the original report | Published: June 03, 2026